Guidelines

2026-04-20

Drugs Guide

Framework on the Use of Real-World Data (RWD) and Real-World Evidence (RWE) to Support Effectiveness and Safety for Marketing Authorization of Medicinal Products

2026-04-12

Drugs Guide

Guideline on good pharmacovigilance practices(GVP)Product- or Population-Specific Considerations III: Advanced Therapy Medicinal Products

2026-04-02

Drugs Guide

Research and Investigational Drugs (RAID) Designation

2026-03-31

Drugs Guide

Guidelines for Variation Requirements

2026-03-09

Drugs Guide

Guidelines for Chemical and Pharmaceutical Quality Documentation of Small Molecules Investigational Product in Clinical Trial

2026-02-02

Drugs Guide

Clinical Considerations for Vaccines

2025-10-21

Drugs Guide

Economic Evaluation Studies Guidelines

2025-10-08

Drugs Guide

Approach of Dealing with Patents When Register Generic Drugs in SFDA

2025-09-30

Drugs Guide

Guideline for Testing of Residual Formaldehyde